Minerva Neurosciences, Inc.
NERV · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $16,803 | $40,012 | $8,491 | $34,229 |
| - Cash | $21,362 | $40,913 | $36,094 | $60,755 |
| + Debt | $60,000 | $82,017 | $73,734 | $0 |
| Enterprise Value | $55,441 | $81,116 | $46,131 | -$26,526 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | $6,024 | -$21,691 | -$24,694 | -$45,280 |
| % Margin | – | – | – | – |
| Net Income | $1,439 | -$30,005 | -$32,109 | -$49,906 |
| % Margin | – | – | – | – |
| EPS Diluted | 0.19 | -4.61 | -6.01 | -9.35 |
| % Growth | 104.1% | 23.3% | 35.7% | – |
| Operating Cash Flow | -$19,551 | -$14,785 | -$24,645 | -$24,602 |
| Capital Expenditures | $0 | $0 | -$16 | $0 |
| Free Cash Flow | -$19,551 | -$14,785 | -$24,661 | -$24,602 |